<tbody id="ff6si"><div id="ff6si"></div></tbody>
  • <track id="ff6si"></track>

    1. <option id="ff6si"></option>

    2. <option id="ff6si"></option>
      1. <track id="ff6si"></track>

          Fresenius Group Overview

          Alternative Performance Measures

          Usage of Alternative Performance Measures

          The Fresenius Group uses alternative performance measures in its regulatory and mandatory publications that may represent so called non-GAAP-measures. These indicators are neither defined by US-GAAP nor by IFRS.

          Within the internal control system of Fresenius non-GAAP-measures are used as key performance indicators.

          The use of non-GAAP-measures for evaluating assets, financial and earnings position of Fresenius is not recommended on an isolated basis or as an alternative to the key performance indicators provided within the consolidated financial statements prepared in accordance with US-GAAP and IFRS.

          The non-GAAP-measures used are listed and explained below:

           

          • Adjustments

            In order to measure the operating performance extending over several periods, key performance measures are “adjusted“ where applicable.
             

            Adjustments may arise from acquisitions/divestitures or the adoption of new accounting standards. Reconciliation tables are available within the respective quarterly or annual report and present the composition of adjustments.

             

             

          • EBIT (Earnings before Interest and Taxes)

            EBIT does include depreciation and write-ups on property, plant and equipment.

            EBIT is calculated by subtracting cost of sales, selling, general and administrative expenses and research and development expenses from sales.

             

          • EBIT margin

            EBIT margin is calculated as the ratio of EBIT to sales.

          • EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization)

            EBITDA is calculated from EBIT by adding depreciations recognized in income and deducting write-ups recognized in income, both, on intangible assets as well as property, plant and equipment.

             

          • EBITDA margin

            EBITDA margin is calculated as the ratio of EBITDA to sales.

          • Cash flow

            Financial key figure that shows the net balance of incoming and outgoing payments during a reporting period.

          • Operating cash flow

            Operating cash flow is a financial measure showing cash inflows from operating activities during a period. Operating cash flow is calculated by subtracting non-cash income and adding non-cash expenses to net income.

          • Cash flow from investing activities

            Cash flow from investing activities is a financial measure opposing payments for the acquisition or purchase of property, plant and equipment and investments versus proceeds from the sale of property, plant and equipment and investments.

          • Cash flow from financing activities

            Cash flow from financing activities is a financial measure showing how the investments of the reporting period were financed.

            Cash flow from financing activities is calculated from additions to equity plus proceeds from the exercise of stock options less dividends paid plus proceeds from debt increase (loans, bonds, senior notes, etc.) less repayments of debt plus the change in noncontrolling interest plus proceeds from the hedge of exchange rate effects due to corporate financing.

          • Cash flow before acquisitions and dividends

            Fresenius uses the cash flow before acquisitions and dividends as the financial measure for free cash flow. Cash flow before acquisitions and dividends is calculated by operating cash flow less investments (net). Net investments are calculated by payments for the purchase of property, plant and equipment less proceeds from the sale of property, plant and equipment.

          • Net Debt/EBITDA

            Net debt/EBITDA is a financial measure reflecting the ability of Fresenius to fulfill its payment obligations. Net debt and EBITDA are calculated at LTM (last twelve month) average exchange rates respectively.

            Calculation of net debt:
            Short-term debt
            + Short-term debt from related parties
            + Current portion of long-term debt and capital lease obligations
            + Current portion of Senior Notes
            + Long-term debt and capital lease obligations, less current portion
            + Senior Notes, less current portion
            + Convertible bonds
            = Debt
            - less cash and cash equivalents
            = Net debt

             

          • Days Sales Outstanding (DSO)

            Indicates the average number of days it takes for a receivable to be paid.

          • Organic growth

            Growth that is generated by a company’s existing businesses and not by acquisitions, divestitures, or foreign exchange impact.

          • Constant currencies
            Constant currencies for income and expenses are calculated using prior year average rates; constant currencies for assets and liabilities are calculated using the mid-closing rate on the date of the respective statement of financial position.
          • ROE (Return on Equity)

            Measure of a corporation’s profitability revealing how much profit a company generates
            with the money shareholders have invested. ROE is calculated by fiscal year’s net income / total equity x 100.

          • ROIC (Return on Invested Capital)

            Calculated by: (EBIT - taxes) / Invested capital

            Invested capital = total assets + amortization of goodwill (accumulated) - deferred tax assets - cash and cash equivalents - trade accounts payable - accruals (without pension accruals) - other liabilities not bearing interest

             

            Reconciliation of average invested capital and ROIC
             

            € in millions, except for ROIC  31.12.2018 31.12.2017 31.12.2016
            Total assets  56,703  53,133  46,697
            Plus: Cumulative goodwill amortization 520 501 553
            Minus: Cash and cash equivalents - 2,709 -?1,636 -?1,579
            Minus: Loans to related parties -60 -?56 -51
            Minus: Deferred tax assets -777 -?744 -627
            Minus: Accounts payable -?1,823  -?1,688 -?1,315
            Minus: Accounts payable to related parties -?67  -?42 -57
            Minus: Provisions and other current liabilities1 -?7,141 -?6,921 -?6,006
            Minus: Income tax payable -?428 -?420 - 478
            Invested Capital 44,218 42,127 37,137
            Average invested capital as of December 31, 2018?/?20172 42,769 43,129 36,271
            Operating income3,4 4,547 4,783 4,291
            Income tax expense5  -?1,000 -?1,349 - 1,206
            NOPAT3,4  3,547 3,434 3,085
            ROIC in %  8.3?% 8.0?% 8.5%


            1 Includes non-current provisions and payments outstanding for acquisition; does not include pension liabilities and noncontrolling interest subject to put provisions.
            2 Includes adjustments for acquisitions in the respective reporting period with a purchase price above a certain level (2018: € - 808 million; 2017: € 6,993 million; 2016: € 378 million).
            3 Includes adjustments for acquisitions in the respective reporting period with a purchase price above a certain level (2018: € - 14 million; 2017: € - 47 million; 2016: € - 11 million).

            4 Before special items
            5 Before book gain from US tax reform (2017)

          • ROOA (Return on Operating Assets)

            Calculated as the ratio of EBIT to operating assets (average).

            Operating assets = total assets - deferred tax assets - trade accounts payable - cash held in trust - payments received on account - approved subsidies


            Reconciliation of average operating assets and ROOA
             

            € in millions, except for ROOA 31.12.2018 31.12.2017 31.12.2016
            Total assets 56,703 53,133 46,697
            Minus: Contract liabilities -108 0 -?87
            Minus: Payments received on account 0 - 53 0
            Minus: Cash held in trust -123 -?183 -?61
            Minus: Loans to related parties -?60 -?56 -?51
            Minus: Deferred tax assets  -777 -?744 -?627
            Minus: Accounts payable -?1,823 -?1,688 -?1,315
            Minus: Accounts payable to related parties -?67 -?42 -?57
            Minus: Approved subsidies due to Hospital Funding Act
            (?Krankenhausfinanzierungsgesetz“, KHG)
            -?150 -?175 -?180
            Operating assets 53,595 50,192 44,319
            Average operating assets as of December 31, 2018?/?20171 50,722 50,717 42,821
            Operating income2, 3 4,547 4,783 4,291
            ROOA in %  9.0?% 9.4?% 10.0%


            1 Includes adjustments for acquisitions in the respective reporting period with a purchase price above a certain level (2018: € - 2,343 million; 2017: € 6,923 million; 2016: € 421 million).
            2 Includes adjustments for acquisitions in the respective reporting period with a purchase price above a certain level (2018: € - 14 million; 2017: € - 47 million; 2016: € - 11 million).
            3 Before special items

          • Scope of Inventory (SOI)

            Indicates the average number of days between receiving goods as inventory and the sale of the finished product.

            Calculated by: (Inventories / Costs of goods sold) x 365 days

          • Before special items

            In order to measure the operating performance extending over several periods, key performance measures are adjusted by special items, where applicable. Adjusted measures are labelled with “before special items”. A reconciliation table is available within the respective quarterly or annual report and presents the composition of special items.

          • Working Capital

            Current assets (including deferred assets) - accruals - trade accounts payable - other liabilities - deferred charges

          青草青青